StonvexLoading…
StonvexStonvexStonvexCore line items from RIME's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.40M | $4.39M | $3.02M | $4.71M |
Operating Income | $-4.34M | $-7.95M | $-3.88M | $-3.59M |
Net Income | $-5.11M | $-15.87M | $-12.74M | $-10.10M |
EPS (Diluted) | $-0.52 | $-6.41 | $-5.45 | $-4.40 |
Total Assets | $18.45M | $12.72M | $10.85M | $12.70M |
Total Liabilities | $15.29M | $14.58M | $10.74M | $9.88M |
Cash & Equivalents | $7.70M | $1.63M | $2.84M | $1.13M |
Free Cash Flow OCF − CapEx | $-3.94M | $-7.32M | $-4.35M | $-5.46M |
Shares Outstanding | 14.65M | 3.41M | 2.64M | 2.51M |